Cargando…

Multiplex CRISPR/Cas9 system impairs HCMV replication by excising an essential viral gene

Anti-HCMV treatments used in immunosuppressed patients reduce viral replication, but resistant viral strains can emerge. Moreover, these drugs do not target latently infected cells. We designed two anti-viral CRISPR/Cas9 strategies to target the UL122/123 gene, a key regulator of lytic replication a...

Descripción completa

Detalles Bibliográficos
Autores principales:	Gergen, Janina, Coulon, Flora, Creneguy, Alison, Elain-Duret, Nathan, Gutierrez, Alejandra, Pinkenburg, Olaf, Verhoeyen, Els, Anegon, Ignacio, Nguyen, Tuan Huy, Halary, Franck Albert, Haspot, Fabienne
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5813945/ https://www.ncbi.nlm.nih.gov/pubmed/29447206 http://dx.doi.org/10.1371/journal.pone.0192602

Ejemplares similares

Human Cytomegalovirus Entry into Dendritic Cells Occurs via a Macropinocytosis-Like Pathway in a pH-Independent and Cholesterol-Dependent Manner
por: Haspot, Fabienne, et al.
Publicado: (2012)

Correction: Human Cytomegalovirus Entry into Dendritic Cells Occurs via a Macropinocytosis-Like Pathway in a pH-Independent and Cholesterol-Dependent Manner
por: Haspot, Fabienne, et al.
Publicado: (2012)

SIRPγ-CD47 Interaction Positively Regulates the Activation of Human T Cells in Situation of Chronic Stimulation
por: Dehmani, Safa, et al.
Publicado: (2021)

The degradation of gelatin/alginate/fibrin hydrogels is cell type dependent and can be modulated by targeting fibrinolysis
por: Boucard, Elea, et al.
Publicado: (2022)

Successful correction of hemophilia by CRISPR/Cas9 genome editing in vivo: delivery vector and immune responses are the key to success
por: Nguyen, Tuan Huy, et al.
Publicado: (2016)

HCMV Infection and Apoptosis: How Do Monocytes Survive HCMV Infection?
por: Collins-McMillen, Donna, et al.
Publicado: (2018)

Association of human cytomegalovirus (HCMV) neutralizing antibodies with antibodies to the HCMV glycoprotein complexes
por: Shibamura, Miho, et al.
Publicado: (2020)

Suppressive effects of pterostilbene on human cytomegalovirus (HCMV) infection and HCMV-induced cellular senescence
por: Wang, Sanying, et al.
Publicado: (2022)

HCMV-Infected Cells Maintain Efficient Nucleotide Excision Repair of the Viral Genome while Abrogating Repair of the Host Genome
por: O'Dowd, John M., et al.
Publicado: (2012)

Insight for Immunotherapy of HCMV Infection
por: Long, Xinmiao, et al.
Publicado: (2021)

Human Cytomegalovirus (HCMV)-infected Astrocytoma Cells Impair the Function of HCMV-specific Cytotoxic T Cells
por: Kim, Jiyeon, et al.
Publicado: (2020)

Lentiviral Vector Pseudotypes: Precious Tools to Improve Gene Modification of Hematopoietic Cells for Research and Gene Therapy
por: Gutierrez-Guerrero, Alejandra, et al.
Publicado: (2020)

Gene cloning of the human cytomegalovirus (HCMV) antigen reactive with the serum from a HCMV-infected patient.
por: Kim, M. N., et al.
Publicado: (1994)

Single Chain Antibodies Against gp55 of Human Cytomegalovirus (HCMV) for Prophylaxis and Treatment of HCMV Infections
por: Moazen, Bahareh, et al.
Publicado: (2016)

A Viral Pilot for HCMV Navigation?
por: Adler, Barbara
Publicado: (2015)

HCMV latency: what regulates the regulators?
por: Elder, Elizabeth, et al.
Publicado: (2019)

HCMV Envelope Glycoprotein Diversity Demystified
por: Foglierini, Mathilde, et al.
Publicado: (2019)

Challenging the Conventional Interpretation of HCMV Seronegativity
por: Waters, Shelley, et al.
Publicado: (2021)

Alveolar Macrophages Isolated Directly From Human Cytomegalovirus (HCMV)–Seropositive Individuals Are Sites of HCMV Reactivation In Vivo
por: Poole, Emma, et al.
Publicado: (2015)

Variants of HCMV UL18 Sequenced Directly from Clinical Specimens Associate with Antibody and T-Cell Responses to HCMV
por: Waters, Shelley, et al.
Publicado: (2022)

The microRNA Transcriptome of Human Cytomegalovirus (HCMV)
por: Meshesha, Mesfin K, et al.
Publicado: (2012)

Increased HCMV seroprevalence in patients with hepatocellular carcinoma
por: Lepiller, Quentin, et al.
Publicado: (2011)

US28: HCMV’s Swiss Army Knife
por: Krishna, Benjamin A., et al.
Publicado: (2018)

Tuning the Orchestra: HCMV vs. Innate Immunity
por: Dell’Oste, Valentina, et al.
Publicado: (2020)

Intragenic variations in the HCMV RL11-family
por: Sekulin, K., et al.
Publicado: (2006)

Small Molecules—Prospective Novel HCMV Inhibitors
por: Bogner, Elke, et al.
Publicado: (2021)

CARs—A New Perspective to HCMV Treatment
por: Bednar, Christopher, et al.
Publicado: (2021)

HCMV Antivirals and Strategies to Target the Latent Reservoir
por: Perera, Marianne R., et al.
Publicado: (2021)

Large-Scale Screening of HCMV-Seropositive Blood Donors Indicates that HCMV Effectively Escapes from Antibodies by Cell-Associated Spread
por: Falk, Jessica Julia, et al.
Publicado: (2018)

Humanized Mice Are Precious Tools for Preclinical Evaluation of CAR T and CAR NK Cell Therapies
por: Mhaidly, Rana, et al.
Publicado: (2020)

Fine Mapping the Interaction Between Dendritic Cell-Specific Intercellular Adhesion Molecule (ICAM)-3-Grabbing Nonintegrin and the Cytomegalovirus Envelope Glycoprotein B
por: Chéneau, Coraline, et al.
Publicado: (2018)

DNA repair mechanisms and human cytomegalovirus (HCMV) infection
por: Smolarz, Beata, et al.
Publicado: (2014)

The influence of HCMV infection on autophagy in THP-1 cells
por: Liu, Yujie, et al.
Publicado: (2017)

Role of Immunogenetics in the Outcome of HCMV Infection: Implications for Ageing
por: Aiello, Anna, et al.
Publicado: (2019)

Understanding HCMV Latency Using Unbiased Proteomic Analyses
por: Poole, Emma, et al.
Publicado: (2020)

Regulation of the MIE Locus During HCMV Latency and Reactivation
por: Dooley, Abigail L., et al.
Publicado: (2020)

Species-Specific Inhibition of Necroptosis by HCMV UL36
por: Muscolino, Elena, et al.
Publicado: (2021)

Towards a Prophylactic Vaccine for the Prevention of HCMV Infection
por: Ligat, Gaëtan, et al.
Publicado: (2021)

ELISPOT assays with pp65 peptides or whole HCMV antigen are reliable predictors of immune control of HCMV infection in seropositive kidney transplant recipients
por: Zavaglio, Federica, et al.
Publicado: (2023)

Genetic and Functional Characterization of Congenital HCMV Clinical Strains in Ex Vivo First Trimester Placental Model
por: Andouard, Deborah, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_e83h40238d2mrfiegfm18s9m39